Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Director Sells 28,405 Shares of Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 28,405 shares of USANA Health Sciences stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $75.39, for a total transaction of $2,141,452.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Shares of USANA Health Sciences, Inc. (NYSE USNA) traded up $0.82 during midday trading on Thursday, hitting $76.92. 14,526 shares of the company’s stock traded hands, compared to its average volume of 89,000. The stock has a market cap of $1,834.23, a price-to-earnings ratio of 19.02 and a beta of 0.99. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $79.00.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, February 6th. The company reported $1.11 EPS for the quarter, topping the consensus estimate of $1.00 by $0.11. The company had revenue of $273.11 million for the quarter, compared to analyst estimates of $258.67 million. USANA Health Sciences had a net margin of 5.97% and a return on equity of 27.02%. The business’s revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.87 EPS. equities analysts anticipate that USANA Health Sciences, Inc. will post 4.25 earnings per share for the current year.

Several institutional investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC boosted its position in shares of USANA Health Sciences by 0.7% in the 4th quarter. Renaissance Technologies LLC now owns 1,930,966 shares of the company’s stock worth $142,988,000 after buying an additional 12,700 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of USANA Health Sciences by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 979,726 shares of the company’s stock worth $62,801,000 after buying an additional 25,136 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of USANA Health Sciences by 5.6% in the 3rd quarter. Dimensional Fund Advisors LP now owns 751,018 shares of the company’s stock worth $43,334,000 after buying an additional 40,100 shares in the last quarter. BlackRock Inc. boosted its position in shares of USANA Health Sciences by 0.4% in the 4th quarter. BlackRock Inc. now owns 725,965 shares of the company’s stock worth $53,758,000 after buying an additional 3,161 shares in the last quarter. Finally, Nordea Investment Management AB boosted its position in shares of USANA Health Sciences by 2.6% in the 3rd quarter. Nordea Investment Management AB now owns 344,217 shares of the company’s stock worth $19,861,000 after buying an additional 8,768 shares in the last quarter. Institutional investors and hedge funds own 45.10% of the company’s stock.

A number of research firms recently weighed in on USNA. Sidoti lowered shares of USANA Health Sciences from a “buy” rating to a “neutral” rating in a research report on Wednesday, January 24th. Pivotal Research boosted their target price on shares of USANA Health Sciences from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, February 7th. TheStreet lowered shares of USANA Health Sciences from a “b+” rating to a “c+” rating in a research report on Tuesday, February 6th. Finally, BidaskClub upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research report on Thursday, October 26th.

TRADEMARK VIOLATION WARNING: “Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Director Sells 28,405 Shares of Stock” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/22/myron-w-wentz-sells-28405-shares-of-usana-health-sciences-inc-usna-stock.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply